US Patent 7666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Patent 7666874 was granted and assigned to Novartis on February, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+614 characters)
Article
Patent abstract
The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of FIP1L1-PDGFRα-induced or TEL-PDGFRβ-induced myeloproliferative diseases, especially for the curative and/or prophylactic treatment of hypereosinophilic syndrome and hypereosinophilic syndrome with resistance to imatinib, and to a method of treating hypereosinophilic syndrome, chronic eosinophilic leukemia and hypereosinophilic syndrome with resistance to imatinib, or other diseases associated with FIP1L1-PDGFRα, TEL-PDGFRβ or similar mutations that activate PDGFR.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Doriano Fabbro0
Jürgen Mestan0
Paul W. Manley0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome US Patent 7666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Infobox
Patent Number
076668740
Patent Number
76668740
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076668740
Date of Patent
February 23, 2010
0Patent Application Number
119115620
Date Filed
May 2, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07666874
Date of patent
February 23, 2010
Patent application number
11911562
Date Filed
May 2, 2006
Patent primary examiner
Find more entities like US Patent 7666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
